DeviceTalks By cover art

DeviceTalks

By: DeviceTalks
Listen for free

  • Summary

  • The DeviceTalks Podcast Network delivers news, insights and commentary from Medtech industry leaders. Our podcasts will inspire medtech professionals to create better medtech devices and companies. Explore the DeviceTalks Podcast Network, home to more than 8 podcasts: • AbbottTalks • AI Meets Life Sci • Boston Scientific Talks • DeviceTalks Weekly • IntuitiveTalks • MedtechWOMEN Talks • MedtronicTalks • Ortho Innovation Talks: Zimmer Biomet • StrykerTalks
    All rights reserved
    Show more Show less
Episodes
  • Abbott’s Kazemi discusses a decade of diabetes advancements and the impact of CGM on diabetes care

    Abbott’s Kazemi discusses a decade of diabetes advancements and the impact of CGM on diabetes care
    Apr 30 2024
    In this episode of AbbottTalks, Mahmood Kazemi, MD, Chief Medical Officer of Abbott’s Diabetes Care business overviews the profound advancements in diabetes management over the past decade and discusses the evolution of treatments and technological innovations that have revolutionized how individuals with diabetes approach their condition. Further, Dr. Kazemi underscores the benefits of advancements such as the GLP-1 receptor agonists and medications that control glucose levels and offer cardiovascular and renal protection. He then elaborates on how Abbott's FreeStyle Libre continuous glucose monitoring (CGM) systems have significantly improved diabetes management. These systems provide real-time data, empowering individuals to customize their medication, diet, and activity levels with unprecedented precision. He also speaks to Abbott's ongoing and future work, including developing a state-of-the-art continuous glucose ketone monitoring (CGKM) sensor. This medical biowearable is designed to provide crucial early warning signs in Type 1 diabetes management, a significant step towards preventing dangerous complications and hospitalizations. Looking to the future, Kazemi anticipates a wider adoption of CGM across the diabetes community, including those with type 2 diabetes, and an increase in insurer coverage. Thank you to BMP Medical for sponsoring this episode of AbbottTalks! For more information on how BMP Medical works with medical device companies, visit www.bmpmedical.com Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.
    Show more Show less
    43 mins
  • It's Here! Share Your Story at DeviceTalks Boston Next Week Where You Can Meet Great Medtech Leaders

    It's Here! Share Your Story at DeviceTalks Boston Next Week Where You Can Meet Great Medtech Leaders
    Apr 26 2024
    In this week’s episode of the DeviceTalks Weekly Podcast, Editorial Director Tom Salemi talks about next week’s DeviceTalks Boston meeting with MedTech Innovator CEO Paul Grand. We also hear interviews done earlier this year with speakers – Bertin Nahum of Quantum Surgical, Kurt Haggstrom of Synchron and Closing Keynote Speaker Rajit Kamal of Medtronic. Anyone interested attending – and meeting a surprise surgical robotics guest – can register at Boston.DeviceTalks.com. Use the code DTWeekly25 to save 25% of the registration fee. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network.
    Show more Show less
    1 hr and 3 mins
  • How do I take an approved medical device to market? with YJ Oh, Edwards Lifesciences

    How do I take an approved medical device to market? with YJ Oh, Edwards Lifesciences
    Apr 23 2024
    In the final episode of MedtechWOMEN Talks season one, we are joined by YJ Oh, SVP US Sales, Marketing and Commercial Operations at Edwards Lifesciences, who takes us through the intricate process of medical device commercialization. Starting with her unique entry into the medtech industry, YJ shares her comprehensive journey from sales to global marketing, emphasizing the significant role of upstream marketing in shaping product development and downstream efforts in executing commercial strategies. In the discussion, YJ highlights the criticality of understanding market needs right from the inception of a product idea, ensuring that every development phase aligns with customer insights and real-world applicability. She provides a glimpse into the key collaborations across various departments and touches on the essential feedback mechanisms in place, ensuring devices meet the stringent requirements and expectations set forth by both regulatory bodies and the end-users, primarily physicians. Her insights extend into the strategic considerations for global market penetration, discussing how different regulatory landscapes affect the accessibility and success of medical devices across borders. TL;DR – Key Takeaways: - The integration of market insights from the beginning is crucial for successful medical device commercialization. - Collaborative efforts across various functions are vital to address the comprehensive demands of product development. - Strategic global considerations are imperative to navigate varying regulatory and market conditions effectively. Thank you to our season one sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical! https://aptyx.com/ https://catalyzehealthcare.com/ https://confluentmedical.com/ https://www.cretex.com/ Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for listening to MedtechWOMEN Talks!
    Show more Show less
    45 mins
Show more Show less

What listeners say about DeviceTalks

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available